These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 11522007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 3. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
    Arnout J, Meijer P, Vermylen J.
    Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies.
    Zhu M, Olee T, Le DT, Roubey RA, Hahn BH, Woods VL, Chen PP.
    Br J Haematol; 1999 Apr; 105(1):102-9. PubMed ID: 10233371
    [Abstract] [Full Text] [Related]

  • 6. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T.
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [Abstract] [Full Text] [Related]

  • 7. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M, Ferrard-Sasson G, Dubucquoi S, Hachulla E, Prin L, Hatron PY, Goudemand J, Boffa MC, Caron C.
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [Abstract] [Full Text] [Related]

  • 8. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M, Dlott J, Norbis F, Ruggeri L, Cler L, Triplett DA, Barbui T.
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [Abstract] [Full Text] [Related]

  • 9. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V, Biasiolo A, Rampazzo P, Brocco T.
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [Abstract] [Full Text] [Related]

  • 10. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D, Boutière B, Sanmarco M.
    Ann Biol Clin (Paris); 2000 Feb; 58(5):557-74. PubMed ID: 11022099
    [Abstract] [Full Text] [Related]

  • 11. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 12. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W, Matthias T, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [Abstract] [Full Text] [Related]

  • 13. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 14. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Jul; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA, Krilis SA.
    Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
    [Abstract] [Full Text] [Related]

  • 16. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M, Finazzi G, Bevers EM, Barbui T.
    Blood; 1995 Jul 15; 86(2):617-23. PubMed ID: 7605991
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T.
    Am J Hematol; 2004 Aug 15; 76(4):338-42. PubMed ID: 15282665
    [Abstract] [Full Text] [Related]

  • 18. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 15; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 19. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
    Bidot CJ, Jy W, Horstman LL, Ahn ER, Yaniz M, Ahn YS.
    Am J Hematol; 2006 Jun 15; 81(6):391-6. PubMed ID: 16680753
    [Abstract] [Full Text] [Related]

  • 20. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Dec 15; 84(12):1065-74. PubMed ID: 10586206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.